
Circulating RNAs extracted from liquid biopsies represent a promising source of cancer and therapy‐related biomarkers. We screened whole blood from patients with metastatic castration‐resistant prostate cancer (mCRPC) following their first‐line treatment with abiraterone acetate and prednisone (AA‐P) to identify circulating RNAs that may correlate with progression free survival (PFS).
Like
Save
Share